Carospir

The following clinically significant adverse reactions are described elsewhere in the labeling:

• Hyperkalemia [see WARNINGS AND PRECAUTIONS]
• Hypotension and Worsening Renal Function [see WARNINGS AND PRECAUTIONS]
• Electrolyte and Metabolic Abnormalities [see WARNINGS AND PRECAUTIONS]
• Gynecomastia [see WARNINGS AND PRECAUTIONS]
• Impaired neurological function/ coma in patients with hepatic impairment, cirrhosis and ascites [see Use In Specific Populations]

The following adverse reactions associated with the use of CAROSPIR were identified in clinical trials or postmarketing reports. Because these reactions were reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency, reliably, or to establish a causal relationship to drug exposure.

Digestive: Gastric bleeding, ulceration, gastritis, diarrhea and cramping, nausea, vomiting.

Reproductive: Gynecomastia [see WARNINGS AND PRECAUTIONS], decreased libido, inability to achieve or maintain erection, irregular menses or amenorrhea, postmenopausal bleeding, breast and nipple pain.

Hematologic: Leukopenia (including agranulocytosis), thrombocytopenia.

Hypersensitivity: Fever, urticaria, maculopapular or erythematous cutaneous eruptions, anaphylactic reactions, vasculitis.

Metabolism: Hyperkalemia, electrolyte disturbances [see WARNINGS AND PRECAUTIONS], hyponatremia, hypovolemia.

Musculoskeletal: Leg cramps.

Nervous system /psychiatric: Lethargy, mental confusion, ataxia, dizziness, headache, drowsiness.

Liver / biliary: A very few cases of mixed cholestatic/hepatocellular toxicity, with one reported fatality, have been reported with spironolactone administration.

Renal: Renal dysfunction (including renal failure).

Skin: Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), drug rash with eosinophilia and systemic symptoms (DRESS), alopecia, pruritis, chloasma.

Read the entire FDA prescribing information for Carospir (Spironolactone)